RxDoctor Payments Data

Nicholas Hernandez

Adult Reconstructive Orthopaedic Surgery · Seattle, WANPI 1679989396

Payments from drug & device makers

What this record shows

This record is dominated by education: $25,667 of the $31,860 with a category attached, or 80.6%. Smith+Nephew accounts for 86.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $15,717 and has fallen 97.6% since, to $375 in 2025.

$31,860in general payments, 2019–2025

Across 77 payments — averaging $413.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$28K
  • Stryker$2K
  • Johnson & Johnson$1K
  • Zimmer Biomet$753
  • Davol Inc.$267
  • Medical Device Business Services, Inc.$167
  • plus $245 from 4 others

What the payments were for

  • Travel & lodging$2,7169%
  • Food & beverage$3,47711%
  • Education$25,66781%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Washingtonto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$138,163
Medicare patients
237
Services billed
424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin18$34

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →